Proteomics research has potential in aging exploration and the development of high throughput assay technologies supports its rapid expansion in aging. CD BioSciences' proteomics research services in aging, including specific assays, technology platforms, and project solutions that complement the understanding of mechanisms of aging and age-related diseases with proteomic information.
We apply state-of-the-art mass spectrometry technologies for aging proteomics studies, providing services including identification and quantification, functional characterization, specific identification, association analysis, and other services.
Proteomic Analysis in Aging Research
CD BioSciences offers proteomic analysis techniques to comprehensively characterize the proteomes of aging-related samples, revealing alterations in protein abundance, post-translational modifications, and protein-protein interactions. Through proteomics, we can identify classes of proteins in different tissues and characterize changes in protein expression to gain insight into aging mechanisms.
Proteome-Based Discovery of Aging-Related Protein Biomarkers
We help our clients discover protein biomarkers that are important tools for aging evaluation and the prevention and treatment of aging-related diseases. We provide multiple discovery strategies to identify aging-related protein biomarkers from biological samples such as tissues and cells. These biomarkers may serve as indicators of biological age, disease risk, or response to interventions.
Proteomic Aging Clock Development Services
CD BioSciences specializes in the development of proteomic aging clocks, leveraging its expertise in proteomics, bioinformatics, and machine learning. Our proteomic aging clocks have demonstrated high accuracy in predicting biological age and age-related outcomes, which are applied to various research applications including longitudinal studies, clinical trials, and personalized medicine.
Aging proteomics services are available from our advanced proteomics technology platform, where experienced personnel will provide solutions and meet the unique needs of your project.
Through comprehensive proteomic analysis, the discovery of aging-related protein biomarkers, and the development of proteomic aging clocks, CD BioSciences is committed to studying the aging process to accelerate the development of healthy aging interventions. If you are interested in our services or have any questions, please feel free to contact us to discuss how we can be involved in your research program.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.